NO892821L - Fremgangsmaate for fremstilling av o2, 2'-anhydro-1-(b-d-arabinofuranosyl) tymin. - Google Patents

Fremgangsmaate for fremstilling av o2, 2'-anhydro-1-(b-d-arabinofuranosyl) tymin.

Info

Publication number
NO892821L
NO892821L NO89892821A NO892821A NO892821L NO 892821 L NO892821 L NO 892821L NO 89892821 A NO89892821 A NO 89892821A NO 892821 A NO892821 A NO 892821A NO 892821 L NO892821 L NO 892821L
Authority
NO
Norway
Prior art keywords
arabinofuranosyl
anhydro
thymin
procedure
preparation
Prior art date
Application number
NO89892821A
Other languages
English (en)
Other versions
NO892821D0 (no
Inventor
Charles William Murtiashaw
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO892821D0 publication Critical patent/NO892821D0/no
Publication of NO892821L publication Critical patent/NO892821L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/09—Pyrimidine radicals with arabinosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Ved den omtalte fremgangsmåte dannes et 0,2'-anhydro-| 1-(6-D-arabinofuranosyl)tymin ved kondensering av et 2-amino-P-arabinofuran[l',2'4,5]-2-oksazolin med en forbindelse med formel. hvori Ri er C-C-alkyl; X er halogen eller 0R, hvori Rer H. C-C-alkyl eller fenyl; i nærvær av et egnet opplasningsmiddel ved rundt 0C til rundt 150C. Katalytiske midler så som dimetylaminopyridin og trietylamin kan også tilsettes for å fremskynde reaksjonen.Beskyttede utgangsforbindelser for anhydronukleosidene og aminooksazolinene er også omtalt.
NO89892821A 1988-07-12 1989-07-07 Fremgangsmaate for fremstilling av o2, 2'-anhydro-1-(b-d-arabinofuranosyl) tymin. NO892821L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/217,906 US5008384A (en) 1988-07-12 1988-07-12 Process for the production of O.sup. 2,2'-anhydro-1-(β-D-arabinofuranosyl)thymine

Publications (2)

Publication Number Publication Date
NO892821D0 NO892821D0 (no) 1989-07-07
NO892821L true NO892821L (no) 1990-01-15

Family

ID=22812966

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89892821A NO892821L (no) 1988-07-12 1989-07-07 Fremgangsmaate for fremstilling av o2, 2'-anhydro-1-(b-d-arabinofuranosyl) tymin.

Country Status (21)

Country Link
US (1) US5008384A (no)
EP (1) EP0351126B1 (no)
JP (1) JPH075626B2 (no)
KR (1) KR910008112B1 (no)
CN (1) CN1039423A (no)
AT (1) ATE117314T1 (no)
AU (1) AU603042B2 (no)
CA (1) CA1315776C (no)
DD (2) DD284024A5 (no)
DE (1) DE68920648T2 (no)
DK (1) DK342189A (no)
ES (1) ES2066853T3 (no)
FI (1) FI893364A7 (no)
GR (1) GR3015293T3 (no)
HU (1) HUT50843A (no)
IE (1) IE65735B1 (no)
IL (1) IL90884A0 (no)
NO (1) NO892821L (no)
PT (1) PT91113B (no)
YU (1) YU138789A (no)
ZA (1) ZA895259B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009599A1 (fr) * 1990-11-30 1992-06-11 Yamasa Shoyu Kabushiki Kaisha PROCEDE DE PRODUCTION DE 1-(2,3-DIDESOXY-β-D-GLYCERO-PENT-2-ENOFURANOSYL)THYMINE
DE69415506T2 (de) * 1994-05-20 1999-08-12 Council Of Scientific And Industrial Research, New Delhi Verfahren zur Herstellung von Beta-Thymidine
CN100368422C (zh) 2000-11-29 2008-02-13 三井化学株式会社 L-核酸衍生物及其合成方法
WO2002079213A1 (en) * 2001-03-30 2002-10-10 Triangle Pharmaceuticals, Inc. Process for the preparation of 2'-halo-$g(b)-l-arabinofuranosyl nucleosides
DE10216426A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Verfahren zur Herstellung von beta-L-2'Deoxy-Thymidin
US7595390B2 (en) 2003-04-28 2009-09-29 Novartis Ag Industrially scalable nucleoside synthesis
RU2361875C2 (ru) 2003-06-30 2009-07-20 Айденикс (Кайман) Лимитед СИНТЕЗ β-L-2'-ДЕЗОКСИНУКЛЕОЗИДОВ
MX2008011719A (es) 2006-03-15 2008-09-24 Novartis Ag Proceso para preparar derivados de acido b-nucleico e intermediarios de los mismos.
US7998967B2 (en) 2008-03-03 2011-08-16 Tosk, Incorporated Methotrexate adjuvants to reduce toxicity and methods for using the same
US11446303B2 (en) 2019-06-21 2022-09-20 Tosk, Inc. Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322747A (en) * 1965-04-01 1967-05-30 Merck & Co Inc Thionocarbonate nucleosides
US3463850A (en) * 1967-01-03 1969-08-26 Merck & Co Inc Arabinofuranosyl 2-thiopyrimidines and pharmaceutical compositions thereof
US3658788A (en) * 1969-06-06 1972-04-25 Salk Inst For Biological Studi Aminooxazolines and products thereof and processes for synthesizing same
US3812098A (en) * 1970-03-19 1974-05-21 Syntex Inc O2,2'-anhydro-1-(beta-d-arabinofuranosyl)-cytosine derivatives and methods of making and related procedures
US3709874A (en) * 1970-03-19 1973-01-09 Syntex Corp 1-beta-d-arabinofuranosyl cytosine derivatives and methods of preparing
US3792040A (en) * 1970-03-19 1974-02-12 Syntex Corp Acyl derivatives of o2,2'-anhydro-1-(beta-d-arabinofuranosyl)-cytosines and methods of preparing
US3920630A (en) * 1970-09-24 1975-11-18 Upjohn Co 2,2{40 -Anhydro-ara-cytidine compounds and process of preparation
SE391183B (sv) * 1971-04-15 1977-02-07 Asahi Chemical Ind 2',3'-0-sulfinylcytidin och syraadditionssalter derav till anvendning som mellanprodukt for framstellning av 2,2'-anhydro-(1-beta-d-arabinofuranosyl) cytosin
US3978042A (en) * 1975-01-31 1976-08-31 The Upjohn Company Process for preparing cyclocytidine derivatives
US4140850A (en) * 1977-08-29 1979-02-20 The Upjohn Company 2,2'-Anhydrotriazine nucleosides and process for preparing the same
JPS5649398A (en) * 1979-09-28 1981-05-02 Yamasa Shoyu Co Ltd Preparation of 1-beta-d-arabinofuranosyl-2,2'-cyclothymine
JPS636557A (ja) * 1986-06-26 1988-01-12 Sharp Corp 微細パタ−ン形成方法

Also Published As

Publication number Publication date
NO892821D0 (no) 1989-07-07
EP0351126B1 (en) 1995-01-18
KR910008112B1 (ko) 1991-10-10
FI893364A0 (fi) 1989-07-11
ZA895259B (en) 1991-02-27
DE68920648D1 (de) 1995-03-02
KR900001704A (ko) 1990-02-27
DE68920648T2 (de) 1995-05-18
PT91113A (pt) 1990-02-08
PT91113B (pt) 1995-01-31
DD284024A5 (de) 1990-10-31
ES2066853T3 (es) 1995-03-16
AU603042B2 (en) 1990-11-01
AU3802089A (en) 1990-04-26
JPH075626B2 (ja) 1995-01-25
DK342189D0 (da) 1989-07-11
CA1315776C (en) 1993-04-06
FI893364A7 (fi) 1990-01-13
JPH0259598A (ja) 1990-02-28
GR3015293T3 (en) 1995-06-30
EP0351126A3 (en) 1990-10-24
IL90884A0 (en) 1990-02-09
HUT50843A (en) 1990-03-28
ATE117314T1 (de) 1995-02-15
YU138789A (en) 1990-12-31
US5008384A (en) 1991-04-16
DD292003A5 (de) 1991-07-18
DK342189A (da) 1990-01-15
CN1039423A (zh) 1990-02-07
EP0351126A2 (en) 1990-01-17
IE65735B1 (en) 1995-11-15
IE892233L (en) 1990-01-12

Similar Documents

Publication Publication Date Title
IE791629L (en) Pyridazinone-substituted benzimidazoles
GB1312536A (en) Hydantoin derivatives
ATE67497T1 (de) Verfahren zur herstellung von thiazolidinedionderivaten.
EP0725074A3 (en) Intermediate compounds for the preparation of androst-3,5-diene-3-carboxy derivatives
DK129282A (da) Fremgangsmaade til fremstilling af indolylethylderivater
GR3005296T3 (no)
NO932431L (no) Fremgangsmaate og mellomprodukter for fremstilling av azabicyklo(2,2,2)oktan-3-iminer
NO892821D0 (no) Fremgangsmaate for fremstilling av o2, 2'-anhydro-1-(b-d-arabinofuranosyl) tymin.
DK0407891T3 (da) 3-methoximinopropionsyreestere og fungicider indeholdende disse
NO934741L (no) Fremgangsmåte for minimalisering og kontroll av ischemiske og reperfusjonsskade
ATE8257T1 (de) Verfahren zur herstellung von 4-chinolinonen.
DK0483633T3 (da) 8-Azabicyclo 3,2,1 octylalkylthiazoliddinoner, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler.
NO901534L (no) Fremgangsmaate ved fremstilling av glutarsyrederivater.
NO923287D0 (no) Fremgangsmaate og mellomprodukter for fremstilling av 6-fluorbenzisotiazoler
NO960308L (no) Terapeutisk aktive benzoksaziner og benzotioanoner
ES481298A1 (es) Un procedimiento para preparar nuevos benzotiazo-derivados.
JPS5645454A (en) Cyclohexanecarboxylic acid derivative and its preparation
AU566359B2 (en) 5-oxo-3/beta (un/substituted phenyl) -2- pyrrolidine propanoic acid
JPS5695165A (en) Preparation of substituted benzoic acid amide
DK201585A (da) 1-(substitueret aryl)-dihydro-1h-pyrrolizin-3,5-(2h,6h)-dioner
ES8201970A1 (es) Procedimiento de obtencion de derivados de 3-aril-5-metilpi-rroles a partir del nitroestirenos y compuestos dicarbonili-cos
NO852471L (no) Fremgangsmaate for fremstilling av heterocyklylfenylformamidiner.